Ultrasound‐Triggered Nanoparticles Induce Cuproptosis for Enhancing Immunogenic Sonodynamic Therapy

J Jia Huang F Fuzhen Hu (School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology Frontiers Science Center for Synthetic Biology (Ministry of Education) Tianjin University Tianjin P. R. China) H Hanchen Zhang (Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing China) Z Zheng Cao (Department of Biochemistry, Stanford University School of Medicine) H Haihua Xiao (Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing P. R. China) Z Zhiying Yang (Department of Hepatobiliary Surgery China−Japan Friendship Hospital Beijing 100029 China) Q Qionghua Jin (Department of Chemistry Capital Normal University Beijing 100048 China) K Kun Shang

Abstract

AbstractCuproptosis, as a novel mechanism of cell death, holds significant promise for tumor therapy. However, existing studies typically employ methods to induce cuproptosis through endogenous or exogenous pathways, which often fail to achieve precise control in both space and time. Herein, polymeric nanoparticles (RC NPs) are developed that enable precise activation of cuproptosis through acoustic control for tumor‐specific treatment. The nanoparticles are fabricated via self‐assembly of a degradable, acoustic‐sensitive polymer (Poly RA) and a metal‐ion‐loadable polyphenol‐structured polymer (Poly MPN). Ultrasound stimulation cleaved the RC NPs, generating reactive oxygen species (ROS) and promoting the release of copper ions from Poly MPN, leading to the aggregation of lipoylated proteins and depletion of iron‐sulfur cluster proteins to introduce cuproptosis. Subsequently, the RC NPs successfully activated the immune system of mice, promoting the maturation of antigen‐presenting cells and the activation of T lymphocytes. The nanoparticles exhibited good biosafety and significant tumor inhibition in both orthotopic and patient‐derived xenograft (PDX) models. These novel nanoparticles provide a promising modality for the treatment of highly aggressive cancers and a valuable avenue for future clinical applications.

Article Details

Volume / Issue Vol. 37, Issue 29
Published July 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (8)

J

Jia Huang

F

Fuzhen Hu

School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology Frontiers Science Center for Synthetic Biology (Ministry of Education) Tianjin University Tianjin P. R. China

H

Hanchen Zhang

Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing China

Z

Zheng Cao

Department of Biochemistry, Stanford University School of Medicine

H

Haihua Xiao

Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing P. R. China

Z

Zhiying Yang

Department of Hepatobiliary Surgery China−Japan Friendship Hospital Beijing 100029 China

Q

Qionghua Jin

Department of Chemistry Capital Normal University Beijing 100048 China

K

Kun Shang